Analysis of Survival Rate and Persistence Predictors of Baricitinib in Real-World Data from a Large Cohort of Rheumatoid Arthritis Patients
S. Parisi,A. Becciolini,M. C. Ditto,P. Del Medico,A. Farina,E. Visalli,A. Molica Colella,F. Lumetti,R. Caccavale,P. Scolieri,R. Andracco,F. Girelli,E. Bravi,M. Colina,A. Volpe,A. Ianniello,V. Nucera,V. Franchina,I. Plate,E. Di Donato,G. Amato,C. Salvarani,L. Gardelli,G. Lucchini,F. De Lucia,F. Molica Colella,M. Priora,D. Santilli,N. Mansueto,G. Ferrero, G. Rovera,A. Fiorenza,R. Vitetta,A. Marchetta,V. Ravagnani,M. Paroli,S. Bernardi,E. Arrigoni,R. Foti,G. Sandri,V. Bruzzese,F. Ometto,A. Bezzi,M. C. Focherini, G. Adorni,F. Mascella,A. Lo Gullo,G. Bianchi,D. Camellino,M. Larosa,O. Addimanda,M. Reta,A. Ariani,E. Fusaro Current research in pharmacology and drug discovery（2024）
Key words
Disease-Modifying Antirheumatic Drugs
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper